Drug details

Morphabond (morphine sulfate extended-release tablets)

type of Opioid Analgesics

Morphabond (morphine sulfate) is an opioid agonist indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

This drug may have the following side effects:

• nausea,
• vomiting,
• dizziness,
• sedation,
• constipation,
• sweating,
• anxiety or unease, and
• euphoric mood

The following drugs are related to Morphabond, either as a replacement or used together:

• Actiq (fentanyl citrate)
• Trilisate (choline magnesium trisalicylate)
• Norpramin (desipramine hydrochloride)
• Exalgo (hydromorphone hydrochloride extended release tablets)
• Simponi Aria (golimumab for infusion)
• Simponi Injection (golimumab injection)
• Vicoprofen (hydrocodone and ibuprofen)
• Reprexain Tablets (hydrocodone bitartrate and ibuprofen)
• Morphine Sulfate Oral Solution (morphine sulfate oral solution)
• Oxecta (oxycodone hcl, usp tablets)
• Xeljanz (tofacitinib tablets)